Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment

Drug repositioning refers to new uses for existing drugs outside the scope of the original medical indications. This approach fastens the process of drug development allowing finding effective drugs with reduced side effects and lower costs. Colorectal cancer (CRC) is often diagnosed at advanced sta...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Rep
Hlavní autoři: Anselmino, L. E., Baglioni, M. V., Malizia, F., Laluce, N. Cesatti, Etichetti, C. Borini, Marignac, V. L. Martínez, Rozados, V., Scharovsky, O. G., Girardini, J., Rico, M. J., Menacho Márquez, M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8047046/
https://ncbi.nlm.nih.gov/pubmed/33854147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-87525-z
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky